These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


473 related items for PubMed ID: 25254611

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Predictive value of ureteral dilation rate in the success of endoscopic correction of vesicoureteral reflux in pediatric patients].
    Argibay IS, Molina Vázquez E, Vela Nieto D.
    Arch Esp Urol; 2008 Mar; 61(2):185-90. PubMed ID: 18491734
    [Abstract] [Full Text] [Related]

  • 24. VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapy.
    Lee JN, Lee SM, Ha YS, Kim BS, Kim HT, Kim TH, Yoo ES, Kwon TG, Chung SK.
    J Pediatr Urol; 2016 Aug; 12(4):255.e1-6. PubMed ID: 27220472
    [Abstract] [Full Text] [Related]

  • 25. Extravesical seromuscular ureteroneocystostomy: an effective and simple operation for treatment of vesicoureteral reflux.
    Salehipour M, Jalaeian H, Shirazi M, Rajabi MJ.
    Urol Int; 2008 Aug; 80(2):208-11. PubMed ID: 18362494
    [Abstract] [Full Text] [Related]

  • 26. Renal scarring is the most significant predictor of breakthrough febrile urinary tract infection in patients with simplex and duplex primary vesico-ureteral reflux.
    Loukogeorgakis SP, Burnand K, MacDonald A, Wessely K, De Caluwe' D, Rahman N, Farrugia MK.
    J Pediatr Urol; 2020 Apr; 16(2):189.e1-189.e7. PubMed ID: 31953013
    [Abstract] [Full Text] [Related]

  • 27. Utility of the distal ureteral diameter on VCUG for grading VUR.
    Cooper CS, Alexander SE, Kieran K, Storm DW.
    J Pediatr Urol; 2015 Aug; 11(4):183.e1-6. PubMed ID: 26189589
    [Abstract] [Full Text] [Related]

  • 28. The Swedish infant high-grade reflux trial: UTI and renal damage.
    Nordenström J, Sjöström S, Sillén U, Sixt R, Brandström P.
    J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
    [Abstract] [Full Text] [Related]

  • 29. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
    Akin Y, Gulmez H, Güntekin E, Baykara M, Yucel S.
    Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
    [Abstract] [Full Text] [Related]

  • 30. Endoscopic treatment of vesicoureteral reflux in children: our experience and analysis of factors affecting success rate.
    Alkan M, Ciftci AO, Senocak ME, Tanyel FC, Buyukpamukcu N.
    Urol Int; 2008 Dec; 81(1):41-6. PubMed ID: 18645270
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.
    Arlen AM, Alexander SE, Wald M, Cooper CS.
    J Pediatr Urol; 2016 Oct; 12(5):288.e1-288.e5. PubMed ID: 27072485
    [Abstract] [Full Text] [Related]

  • 33. Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux.
    Baydilli N, Selvi I, Pinarbasi AS, Akinsal EC, Demirturk HC, Tosun H, Demirci D.
    J Pediatr Urol; 2021 Feb; 17(1):68.e1-68.e8. PubMed ID: 33272864
    [Abstract] [Full Text] [Related]

  • 34. Clinical outcome after endoscopic therapy for occult vesicoureteral reflux in females: preliminary results of a retrospective case series.
    Pichler R, Heidegger I, Schlenck B, Horninger W, Oswald J.
    Scand J Urol; 2014 Aug; 48(4):387-92. PubMed ID: 24679246
    [Abstract] [Full Text] [Related]

  • 35. Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.
    Moriya K, Mitsui T, Kitta T, Nakamura M, Kanno Y, Kon M, Nishimura Y, Shinohara N, Nonomura K.
    J Urol; 2015 Feb; 193(2):637-42. PubMed ID: 25111912
    [Abstract] [Full Text] [Related]

  • 36. Can distal ureteral diameter measurement predict primary vesicoureteral reflux clinical outcome and success of endoscopic injection?
    Payza AD, Hoşgör M, Serdaroğlu E, Sencan A.
    J Pediatr Urol; 2019 Oct; 15(5):515.e1-515.e8. PubMed ID: 31420285
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children.
    Chen JJ, Mao W, Homayoon K, Steinhardt GF.
    J Urol; 2004 May; 171(5):1907-10. PubMed ID: 15076307
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Downgrading of high-grade vesicoureteral reflux is a reliable option in the treatment of children with grade IV‒V reflux accompanied by breakthrough infections.
    Kocherov S, Arafeh WA, Zeldin A, Ostrovsky IA, Ioscovich A, Farkas A, Chertin B.
    J Pediatr Urol; 2013 Apr; 9(2):212-6. PubMed ID: 22391110
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.